Sep 6, 2018 Xenon expands ion channel neurology pipeline with addition of XEN496 for the treatment of epilepsy Xenon expands ion channel neurology pipeline with addition of XEN496 for the treatment of epilepsyXenon Pharmaceuticals (NASDAQ:XENE) expands its ion channel product pipeline with XEN496 (active ingredient ezogabine), a Kv7 potassium ... read morePublished on 2018-09-06